Figure 2.

Pregnancy outcome in relation to culture-positive (C+) AF and anti-Ureaplasma antibodies (Ab+) in maternal serum. (A) Ureaplasma sp. detected by culture technique. Antibodies determined by ELISA and semi-quantitation of antibody titer; adverse pregnancy outcome defined as fetal loss, stillbirth, pre-term delivery, and low birth weight. Genetic amniocentesis was performed at 16–20 weeks of gestation; no gestational age provided for the PTL and PPROM groups. (B) Odds ratios (OR) and relative risks (RR) for adverse pregnancy outcome in culture-positive/antibody-positive (C⁺Ab⁺) vs. C⁺Ab⁻ were calculated for each group. Data extracted and adapted from Horowitz et al. (26).